Strimvelis

Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy
Bloomberg
Tue, 03/6/18 - 09:42 am
gene therapy
bubble boy syndrome
GSK
Strimvelis
Orchard Therapeutics
OTL-101
GSK picks up NICE recommendation for Strimvelis, a €594,000 gene therapy
Fierce Pharma
Mon, 10/23/17 - 09:55 pm
GSK
NICE
UK
Strimvelis
gene therapy
ADA-SCID
GlaxoSmithKline's talk of leaving rare diseases—amid slow Strimvelis sales—highlights challenges in the field
Fierce Pharma
Thu, 07/27/17 - 07:33 pm
GSK
Rare Diseases
Strimvelis
GSK enters pay-for-performance deal for gene therapy
BioPharma Dive
Wed, 08/17/16 - 06:39 pm
GSK
pay-for-performance
gene therapy
ADA-SCID
Strimvelis
GSK gene therapy for rare immune disorder wins EMA approval
BioPharma Dive
Mon, 04/4/16 - 07:58 am
GSK
gene therapy
Strimvelis
Europe
ADA-SKID
GSK wins European regulator nod for new gene therapy
Fierce Biotech
Fri, 04/1/16 - 10:03 pm
GSK
Europe
gene therapy
Strimvelis